> Regulatory Affairs Strategy Development
> FDA Submissions:
Investigational New Drug
Applications (INDs)
New Drug
Applications (NDAs)
510(k)s
Investigational Device Exemptions
(IDEs)
Pre-Market Approval (PMA)
>
Analyte Specific Reagent (ASR) Regulatory Compliance
> FDA Registered U.S. Agent for Foreign Manufacturers
>
Training Programs/Seminars/Distance
Education
> Continuing Medical Education (CME)
content development
> CPT Coding, Diagnostic
Reimbursement issues
> Due Diligence
> HIPAA & CFR 21 Part 11
Compliance
> Quality Systems Compliance (QSRs,
QA/QC, GMPs, SOPs)
|